A patient with SCA17 featuring 41 CAG repeats presents with spastic paraplegia and involuntary movement

Yuting Ren,Kang Zhang,Qian Zhang,Bin Chen,Songtao Niu,Xingao Wang,Zaiqiang Zhang
DOI: https://doi.org/10.1016/j.parkreldis.2021.06.021
2021-08-01
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Spinocerebellar ataxia 17 (SCA17) is among the most heterogeneous forms of autosomal dominant cerebellar ataxia; it is caused by triplet repeat expansions within the TATA box-binding protein (<em>TBP</em>) gene. Its features include ataxia, dementia, involuntary movement and psychiatric symptoms, with parkinsonism and dystonia being common manifestations. However, SCA17 is a complex disease with extensive phenotypic variability. Alleles with 50 or greater CAG/CAA repeats are pathologic with full penetrance, while alleles with 43 to 49 CAG/CAA repeats have a reported penetrance between 50% and 80%. We describe our experience with a patient with SCA17 who presented with spastic paraplegia and tremors; she had 41 CAG/CAA repeats in the <em>TBP</em> gene. The features of this patient, along with those of the others described in the literature [<a class="workspace-trigger" href="#bib1">[1]</a>, <a class="workspace-trigger" href="#bib2">[2]</a>, <a class="workspace-trigger" href="#bib3">[3]</a>, <a class="workspace-trigger" href="#bib4">[4]</a>, <a class="workspace-trigger" href="#bib5">[5]</a>, <a class="workspace-trigger" href="#bib6">[6]</a>], suggest that 41 CAG/CAA trinucleotides should be considered a cutoff value for manifestation of a SCA17 phenotype.</p>
clinical neurology
What problem does this paper attempt to address?